Etamsylate 250mg Tablets

Etamsylate 250mg is a haemostatic medicine used to reduce or prevent abnormal bleeding for etamsylate treatment. It may be prescribed for heavy menstrual bleeding, dysfunctional uterine bleeding, or to reduce bleeding around delicate surgical or dental procedures under medical supervision. Etamsylate supports capillary stability and platelet adhesion, helping reduce oozing from small blood vessels without acting like a conventional anticoagulant reversal agent. Medical review is important if bleeding is new, recurrent, unusually heavy, associated with pelvic pain, dizziness, fainting, black stools, blood in urine, or easy bruising.
Take Etamsylate 250mg exactly as prescribed. Do not use it repeatedly for unexplained bleeding without evaluation. Track bleeding pattern and report dizziness, fainting, severe pain, large clots, or ongoing heavy bleeding.
Etamsylate improves capillary wall stability and supports platelet adhesion at small blood vessels, helping reduce capillary bleeding and oozing.
Possible effects include nausea, abdominal discomfort, headache, skin rash, fever, dizziness, and low blood pressure symptoms. Serious warning signs include severe allergy, worsening bleeding, chest pain, leg swelling, severe headache, or fainting.
Bleeding cause should be assessed. Tell the clinician about clot history, porphyria, kidney/liver disease, pregnancy, breastfeeding, anticoagulants, antiplatelets, hormonal therapy, anemia, and any unexplained or postmenopausal bleeding.
Heavy menstrual bleeding, dysfunctional uterine bleeding, and prevention or reduction of capillary bleeding around selected procedures when prescribed.
Can reduce capillary bleeding and menstrual blood loss in selected patients while the underlying cause is assessed and managed.
Etamsylate 250mg is used to reduce abnormal bleeding when etamsylate is prescribed.
No. Heavy, unexplained, or emergency bleeding needs medical assessment and may need other treatment.
No. Etamsylate is a haemostatic medicine, not an anticoagulant.
Fainting, severe dizziness, very heavy bleeding, black stools, severe pain, or pregnancy-related bleeding needs urgent review.
Recurring heavy menstrual bleeding should be evaluated to identify the cause and rule out anemia or gynecologic disease.
Etamsylate, Ethamsylate bleeding medicine, Heavy menstrual bleeding treatment, Haemostatic medicine, Capillary bleeding control, Dysfunctional uterine bleeding, AR: Etamsylate أقراص, FR: Etamsylate comprimé, PT: Etamsylate comprimido, ES: Etamsylate tableta, RU: Etamsylate таблетки, ID: Etamsylate, VI: Etamsylate viên nén, MS: Etamsylate, TL: Etamsylate tableta, ZH-SG: Etamsylate 片剂
International B2B Enquiry
Send a structured B2B enquiry for Etamsylate 250mg Tablets under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Etamsylate 250mg Tablets